Search Page

1

Cite

Share

Letter by Tracey regarding article, "Bypassing big pharma".

Tracey WR. Tracey WR. Circulation. 2008 Mar 18;117(11):e194; author reply e195. doi: 10.1161/CIRCULATIONAHA.107.743013. Circulation. 2008. PMID: 18347216 No abstract available.

Cite

Share

2

Cite

Share

Treatment of peripheral artery disease: an unmet medical need.

Tracey WR, Knight DR. Tracey WR, et al. Curr Opin Investig Drugs. 2009 Sep;10(9):899-901. Curr Opin Investig Drugs. 2009. PMID: 19705331 Review. No abstract available.

Cite

Share

3

Cite

Share

Zoniporide: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1).

Tracey WR, Allen MC, Frazier DE, Fossa AA, Johnson CG, Marala RB, Knight DR, Guzman-Perez A. Tracey WR, et al. Cardiovasc Drug Rev. 2003 Spring;21(1):17-32. doi: 10.1111/j.1527-3466.2003.tb00103.x. Cardiovasc Drug Rev. 2003. PMID: 12595915 Review.

Cite

Share

4

Cite

Share

Nitric oxide synthase isozymes antibodies.

Pollock JS, Förstermann U, Tracey WR, Nakane M. Pollock JS, et al. Among authors: tracey wr. Histochem J. 1995 Oct;27(10):738-44. Histochem J. 1995. PMID: 8575937 Review.

Cite

Share

5

Cite

Share

Harbinger for the era of personalized medicine?

Tracey WR. Tracey WR. Mol Interv. 2005 Aug;5(4):200; author reply 200. doi: 10.1124/mi.5.4.1. Mol Interv. 2005. PMID: 16123532 No abstract available.

Cite

Share

6

Cite

Share

Niche drugs aren't a cheap alternative to blockbusters.

Tracey WR. Tracey WR. Nature. 2007 Feb 22;445(7130):818. doi: 10.1038/445818c. Nature. 2007. PMID: 17314952 No abstract available.

Cite

Share

7

Cite

Share

Isoforms of nitric oxide synthase: functions in the cardiovascular system.

Förstermann U, Nakane M, Tracey WR, Pollock JS. Förstermann U, et al. Among authors: tracey wr. Eur Heart J. 1993 Nov;14 Suppl I:10-5. Eur Heart J. 1993. PMID: 7507435 Review.

Cite

Share

8

Cite

Share

Issues in bringing new drugs to the market.

Tracey WR. Tracey WR. Science. 2005 Dec 2;310(5753):1425-6; author reply 1425-6. Science. 2005. PMID: 16329172 No abstract available.

Cite

Share

9

Cite

Share

The sulfonylurea glipizide does not inhibit ischemic preconditioning in anesthetized rabbits.

Flynn DM, Smith AH, Treadway JL, Levy CB, Soeller WC, Boettner WA, Wisniecki P, Plowchalk DR, Gernhardt SS, Tracey WR, Knight DR. Flynn DM, et al. Among authors: tracey wr. Cardiovasc Drugs Ther. 2005 Oct;19(5):337-46. doi: 10.1007/s10557-005-4970-2. Cardiovasc Drugs Ther. 2005. PMID: 16382296

Cite

Share

10

Cite

Share

Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor.

Tracey WR, Treadway JL, Magee WP, Sutt JC, McPherson RK, Levy CB, Wilder DE, Yu LJ, Chen Y, Shanker RM, Mutchler AK, Smith AH, Flynn DM, Knight DR. Tracey WR, et al. Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H1177-84. doi: 10.1152/ajpheart.00652.2003. Epub 2003 Nov 13. Am J Physiol Heart Circ Physiol. 2004. PMID: 14615278 Free article.

Cite

Share